# A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors

> **NCT00259935** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 107 (actual)

## Conditions studied

- Lung Cancer, Small Cell

## Interventions

- **DRUG:** topotecan

## Key facts

- **NCT ID:** NCT00259935
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10-04
- **Primary completion:** 2007-07-05
- **Final completion:** 2007-07-05
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2017-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259935, "A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00259935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*